Ciclopirox
- Generic Name
- Ciclopirox
- Brand Names
- Ciclodan, Cnl8, Loprox, Penlac, Stieprox
- Drug Type
- Small Molecule
- Chemical Formula
- C12H17NO2
- CAS Number
- 29342-05-0
- Unique Ingredient Identifier
- 19W019ZDRJ
- Background
Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.
- Indication
Used as a topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum.
- Associated Conditions
- Fungal skin infection, Pityriasis versicolor, Seborrheic dermatitis of the scalp, Tinea Corporis, Tinea Cruris, Tinea Pedis, Vulvovaginal Candidiasis, Cutaneous candidiasis, Mild Onychomycosis, Moderate Onychomycosis
- Associated Therapies
- -
The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- 9305-9954 Quebec Inc
- Target Recruit Count
- 120
- Registration Number
- NCT02644551
- Locations
- 🇨🇦
Clinique podiatrique de Montréal, Montreal, Quebec, Canada
Safety Study of Ciclopirox Olamine Cream for Dermatomycoses in Children
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2012-07-20
- Lead Sponsor
- Ferrer Internacional S.A.
- Target Recruit Count
- 21
- Registration Number
- NCT01646580
Topical Penlac Nail Lacquer for Onychomycosis in Children
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2011-08-18
- Lead Sponsor
- Rady Children's Hospital, San Diego
- Target Recruit Count
- 40
- Registration Number
- NCT01419847
- Locations
- 🇺🇸
Children's Hospital-San Diego, San Diego, California, United States
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
- Conditions
- Locations
- 🇺🇸
University of Medicine and Dentistry of NJ, Newark, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.